Asima Zehra¹*, Megha GK² and Afnan Saleem³

¹PhD Scholar, Veterinary Public Health and Epidemiology, India
²PhD Scholar, Division of Veterinary Public Health and Epidemiology, Indian Veterinary Research Institute (IVRI), Bareilly, India
³Scholar, Division of Animal Biotechnology, F. V. Sc. and A.H., Shuhama, Sher- E-Kashmir University of Agriculture Sciences and Technology-Kashmir (SKUAST-K), Jammu and Kashmir UT, India

*Corresponding Author:Asima Zehra, PhD Scholar, Veterinary Public Health and Epidemiology, India.

Received: August 19, 2022; Published: October 10, 2022

Abstract

Zika virus (ZIKV) is an arbovirus and is recognised to be present in multiple areas of Africa, Asia, and the Pacific Islands. ZIKV will continue to spread into more remote areas until new vaccines, antiviral medications, and vector control strategies are developed and put into practice. Additionally, most cases of the ZIKV infections are asymptomatic and can easily be misdiagnosed because the sole test for ZIKV is cross reactive with dengue antibodies. Furthermore, there is still a lot does not know about the virus especially its neurological complications in neonates. But as the anxieties about the world subsided, financing and attention waned. Also, due to the engagement of laboratories in COVID-19 diagnoses taking into account the succeeding waves of the pandemic, the same level of ZIKV public health surveillance could not be maintained after 2020. Thus, the aim of this review on ZIKV epidemiology was to provide the updated figure related to its infection especially in India that can highlight the fact that only active surveillance can be used to follow a disease like ZIKV disease and comprehend its effects on the healthcare system.

Keywords: Zika virus (ZIKV); Epidemiology; India; ICMR; Microcephaly

References

1. Weaver S. “C-102 Zika virus”. JAIDS Journal of Acquired Immune Deficiency Syndromes 74 (2017):
2. Shen S., et al. “Phylogenetic analysis revealed the central roles of two African countries in the evolution and worldwide spread of the Zika virus”. Virologica Sinica 2 (2016): 118-130.
3. Asad H and Carpenter D. “Effects of climate change on the spread of zika virus: a public health threat”. Reviews on Environmental Health1 (2018): 31-42.
4. Pan American Health Organization (PAHO), World Health Organization (WHO). Zika Suspected and Confirmed Cases Reported by Countries and Territories in the Americas Cumulative Cases, 2015-2017. Washington: PAHO/WHO (2017).
5. WHO, Situation report. Zika virus microcephaly Guillain-Barré syndrome (2017).
6. Agarwal A and Chaurasia D. “The expanding arms of Zika virus: An updated review with recent Indian outbreaks”. Reviews In Medical Virology1 (2020): 1-9.
7. Baud D., et al. “An update on Zika virus infection”. The Lancet10107 (2017): 2099-2109.
8. WHO, countries and territories with current or previous zika virus transmission (2019).
9. “Zika travel information”.
10. Smithburn KC., et al. “Neutralising antibodies against certain viruses in the sera of residents of India”. The Journal of Immunology 72 (1954): 248-257.
11. Sapkal G., et al. “First laboratory confirmation on the existence of Zika virus disease in India”. Journal of Infection 3 (2018): 314-317.
12. Singh H., et al. “First report on the transmission of Zika virus by Aedes (Stegomyia) aegypti (L.) (Diptera: culicidae) during the 2018 Zika outbreak in India”. Acta Tropica 199 (2018): 105114.
13. Bhardwaj S., et al. “Zika virus: current concerns in India”. Indian Journal of Medical Research 146 (2017): 572-575.
14. Heymann DL., et al. “Zika virus and microcephaly: why is this situation a PHEIC?” Lancet 387 (2016): 719-721.
15. Yadav P., et al. “Zika a Vector Borne Disease Detected in Newer States of India Amidst the COVID-19 Pandemic”. Frontiers In Microbiology 13 (2022).
16. Department of Health Research. “Govt of India. Establishment of a Network of Laboratories for Managing Epidemics and Natural Calamities (VRDL) (2022).
17. Singh R., et al. “Cluster containment strategy: addressing Zika virus outbreak in Rajasthan, India”. BMJ Global Health 4 (2019): e001383.
18. Rolph MS and Mahalingam S. “Zika’s passage to India”. The Lancet Infectious Diseases 19 (2019): 469-470.
19.  

Citation

Citation: Asima Zehra.,et al. “Zika Virus Epidemiology: An Overview, India".Acta Scientific Veterinary Sciences 4.11 (2022): 37-40.

Copyright

Copyright: © 2022 Asima Zehra., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.